Healthtech Startups

Rubis Santé is a healthcare logistics and patient transport coordination platform designed for hospitals and medical facilities. It provides real-time tracking of internal and external patient transports, integrates with electronic medical records, and enables coordination across multiple sites and departments while ensuring regulatory compliance and data security.

1 investor

SynOx Therapeutics develops emactuzumab, a monoclonal antibody treatment for tenosynovial giant cell tumours (TGCT) and macrophage-mediated diseases. The company focuses on bringing a differentiated drug candidate through clinical development and commercialisation to address unmet patient needs in rare and debilitating diseases.

1 investor

SynsoryBio develops protein-based drugs that detect their location in the body and activate only at diseased tissue, with applications across cancer and autoimmune conditions.

1 investor

SynthBiome designs synthetic growth media that replicate the physiological conditions bacterial pathogens encounter in human infection sites, including media mimicking cystic fibrosis sputum and chronic wound environments. Its models serve researchers and clinical teams for drug development and antibiotic treatment selection.

1 investor

SynThera develops bioactive glass-based biomaterials and specialty glass products for healthcare, industrial, and consumer applications including bone tissue regeneration, dental repair, skincare, and technical glass for electronics and aerospace. The company serves pharmaceutical, medical device, cosmetics, FMCG, and industrial sectors with a focus on high-purity glass materials.

1 investor

Syntilio offers a platform for healthcare organizations that combines intelligent monitoring, triage, and care coordination, translating client signals into care actions and organizing appropriate follow-up. It integrates with electronic health records (ECDs) and e-health applications to support triage of unplanned care in the Dutch healthcare sector.

1 investor

SynVaccine develops technology for the computer-aided design and construction of viral genomes, applying synthetic and computational biology to create viral-based products such as vaccines and viral-based therapeutics. The company targets applications in human pharma and animal health.

1 investor

Synvect develops ngSIT (next-generation sterile insect technique) technology to control mosquito-borne disease vectors through genetic engineering. The company serves public health organizations and disease control programs targeting mosquito-borne diseases worldwide.

1 investor

Kids Public operates telemedicine consultation services for pediatric and obstetric care, as well as medical journals in these specialties, serving patients seeking remote healthcare guidance in Japan.

1 investor

Syremis Therapeutics is a clinical-stage biopharmaceutical company developing neuropsychiatric medicines based on mechanisms including muscarinic M1/M4 agonism and NMDA antagonism. Its pipeline includes ST-905, a dual M1/M4 agonist in Phase 1 for schizophrenia, and ST-901, an NMDA antagonist in IND-enabling studies for major depressive disorder and bipolar depression.

1 investor

symu develops a portable endo-urology simulator for medical training, housed in a wheeled case with removable urinary tract components and interchangeable kidney stones and tumors.

1 investor

Syrona Health provides virtual healthcare support for employees across different life stages, addressing health transitions and personal challenges. The platform combines personalized clinical expertise with technology to deliver outcomes for employers seeking to improve employee benefits and wellbeing.

1 investor

SystemOne connects internet-enabled medical diagnostic devices to collect and transmit data, helping countries and medical device makers monitor device fleets, track disease outbreaks, and manage diagnostic supply chains. The company focuses on improving healthcare and disease response in developing countries.

1 investor

Green World Solutions is an Estonian company behind the Black Stuff brand, which produces dietary supplements designed to support microbiome health and immunity. The company collaborates with an Institute of Innovative Biomedical Technologies and conducts third-party laboratory testing of its natural-ingredient products.

1 investor

Systole Health provides tailored clinical workflows and implementation support for healthcare organizations, aimed at improving patient outcomes, reducing wait times, and increasing revenue.

1 investor

Szpital na Klinach is a private hospital in Kraków, Poland, offering specialized competence centers and surgical care using minimally invasive methods such as laparoscopy, endoscopy, and robotic surgery. It provides treatment across areas including gynecology, urology, orthopedics, oncological surgery, plastic surgery, and outpatient specialist clinics.

1 investor

1 investor

T2S Group is a Moroccan group of companies specializing in health technology, distributing medical equipment, medical devices (imaging, biological analysis, cardiovascular), pharmaceutical products, in vitro diagnostics, and developing medical information systems such as PACS and radiology information systems. It serves healthcare providers across Morocco and several African countries, also offering clinical training, after-sales maintenance, and on-site project support.

1 investor

TA Ventures is an early-stage venture capital firm that invests in and supports technology startups across markets including the US, Europe, Southeast Asia, Latin America, and Africa. Its investment interests span consumer tech, marketplaces, deeptech, fintech, AI, and agtech.

1 investor

tab32 is a cloud-based dental practice management platform that combines scheduling, charting, imaging, billing, AI diagnostics, and patient communication for solo and small dental practices (Alpine) and multi-location groups and DSOs (Summit). The platform runs entirely in the browser with no server infrastructure required.

1 investor

Tabiat provides a dedicated nursing team that monitors patients continuously and coordinates care in partnership with healthcare providers, particularly for chronic conditions like COPD. The team works alongside an AI platform to identify at-risk patients and deliver timely interventions and patient support.

1 investor

Tabula Bio uses machine learning to design in-context DNA algorithms that can outpace microbial evolution and treat infectious disease, positioning itself as an alternative to traditional antibiotic and drug development. The company applies AI to design new DNA faster than pathogens can evolve resistance, and states it is already treating patients.

1 investor

AnewHealth (formed in 2023 by combining ExactCare Pharmacy and Tabula Rasa Healthcare) is a national medication management and pharmacy care provider offering clinical pharmacy services, pharmacy benefit management, and its proprietary MedWise medication-optimization technology. It serves patients with complex, chronic care needs along with healthcare providers and payers across the United States, including PACE and government programs.

1 investor

Tachin.ai offers an AI-native platform that lets healthcare organizations design, simulate, and deploy agentic workflows connecting clinicians, payors, labs, pharma, and government participants. Its Health Orchestration Network provides a decentralized, privacy-preserving coordination layer with a visual build environment and interoperability with existing systems like EHRs, CRMs, and lab platforms.

1 investor